Original Research
Published on 23 Sep 2025
Prolactin and DNA damage trigger an anti-breast cancer cell immune response
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1586062
- 273 views
Type at least 3 characters
1,284 articles
Original Research
Accepted on 15 Sep 2025
Diagnosis and treatment of Paragangliomas and Pheochromocytomas: A survey from the Italian Association for Neuroendocrine Tumors (ITANET)
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1687570
- 632 views
Original Research
Accepted on 15 Sep 2025
[68Ga]Ga-PSMA-11 PET/CT in Medullary Thyroid Carcinoma: Comparison with [18F]FDG PET/CT and Immunohistochemical Analysis
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1627500
- 661 views
Review
Accepted on 15 Sep 2025
Artificial Intelligence-Driven Approaches in Pituitary Neuroendocrine Tumors: Integrating Endocrine-Metabolic Profiling for Enhanced Diagnostics and Therapeutics
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1618412
- 677 views
Original Research
Accepted on 09 Sep 2025
Endoscopic endonasal intradural pituitary transposition for resecting retroinfundibular lesions: technique notes and a single institute experience
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1547980
- 846 views
Systematic Review
Accepted on 09 Sep 2025
Initial Symptoms and Diagnostic Delay in Immune Checkpoint Inhibitor-Related Adrenal Insufficiency: A Systematic Review and Meta-Ethnography of Case Reports
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1636452
- 414 views
Original Research
Accepted on 08 Sep 2025
The Diagnostic Value of Prostate Health Index Combined with Soluble E-Cadherin for Prostate Cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1531866
- 483 views
Original Research
Published on 08 Sep 2025
A machine learning model for predicting bone and/or lung metastasis in differentiated thyroid carcinoma: enhancing precision in risk stratification
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1528392
- 890 views
Original Research
Accepted on 05 Sep 2025
Serum Metabolomics-Based Diagnostic Biomarkers for Colorectal Cancer: Insights and Multi-Omics Validation
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1663938
- 6,537 views
Original Research
Accepted on 04 Sep 2025
Sustained testosterone suppression: prognostic indicator in advanced hormone sensitive prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1652941
- 582 views
Original Research
Published on 04 Sep 2025
The relationship between remnant cholesterol and WHO grade of pancreatic neuroendocrine neoplasms
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1616523
- 632 views
Original Research
Accepted on 01 Sep 2025
Synergistic Impact of Dysglycemia and HPV on Cervical Cancer Risk: A Potential Mediating Role of Ki-67
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1422881
- 336 views
Original Research
Published on 01 Sep 2025
Management of type I gastric-neuroendocrine tumors: the less the better?
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1666699
- 923 views
Correction
Published on 29 Aug 2025
Correction: The impact of altered gut microbiota and lipid metabolism on the progression of endometrial cancer in overweight populations
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1681661
- 498 views
Mini Review
Published on 29 Aug 2025
Dual-tracer 18F-FDG and 18F-AlF-NOTA-octreotide PET/CT imaging in oncocytic thyroid adenoma: a case report and literature review
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1612851
- 821 views
Original Research
Accepted on 28 Aug 2025
Beyond castration: defining maximal testosterone control in advanced prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1634966
- 229 views